摘要
目的:为中药注射剂临床合理使用提供参考。方法:对我院2011-2014年中药注射剂的品种、销售金额、用药频度(DDDs)、日均费用(DDC)等进行分析。结果:我院2011-2014年中药注射剂使用品种和销售金额都较为稳定。活血化瘀类的疏血通注射液(黑龙江)、丹红注射液、舒血宁注射液的销售金额在4年中均排名前列。DDDs排序前3位的疏血通注射液、舒血宁注射液(黑龙江)、丹红注射液/注射用血栓通与销售金额排序相对一致。中药注射剂的DDC在100元左右。药物利用指数几乎全部等于1或接近1。结论:我院中药注射剂所选品种用药金额与DDDs同步性较好,中药注射剂在我院的使用较为稳定、基本合理,价格适中且疗效确切的中药注射剂在临床应用中占有较大份额,具有抗菌消炎作用的清热解毒类中药注射剂用量增长快。
OBJECTIVE：To provide reference for rational application of TCM injection. METHODS：The utilization of TCM injection in our hospital during 2011-2014 was analyzed in terms of species,consumption sum,DDDs and DDC,etc. RESULTS：The type and consumption sum of TCM injection kept stable in our hospital during 2011-2014. TCM injection for activating blood circulation to dissipate blood stasis as Shuxuetong（Heilougjiang）,Danhong,Shuxuening took up the front of consumption sum in4 years. Top 3 TCM injections in the list of DDDs were Shuxuetong,Shuxuening（Heilougjiang）, Danhong/Xueshuangtong corresponded to consumption sum. DDC of TCM injection were kept around 100 yuan. DUI ratio of TCM injection were almost equal to1 or close to 1. CONCLUSIONS：The amount and DDDs of TCM injection are synchronous in our hospital,and the utilization of TCM injection is stable and rational basically in our hospital. TCM injection with suitable price and definite efficacy take up a large share,and the amount of TCM injection for clearing away heat and toxic material with anti-inflammatory effect increase rapidly.
出处
《中国药房》
CAS
北大核心
2015年第29期4063-4065,共3页
China Pharmacy
